BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 7694367)

  • 1. Inhibition by cAMP of Ras-dependent activation of Raf.
    Cook SJ; McCormick F
    Science; 1993 Nov; 262(5136):1069-72. PubMed ID: 7694367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3',5'-monophosphate.
    Wu J; Dent P; Jelinek T; Wolfman A; Weber MJ; Sturgill TW
    Science; 1993 Nov; 262(5136):1065-9. PubMed ID: 7694366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylcholine muscarinic m1 receptor regulation of cyclic AMP synthesis controls growth factor stimulation of Raf activity.
    Russell M; Winitz S; Johnson GL
    Mol Cell Biol; 1994 Apr; 14(4):2343-51. PubMed ID: 8139539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects on cAMP on the MAP kinase cascade: evidence for a cAMP-insensitive step that can bypass Raf-1.
    Faure M; Bourne HR
    Mol Biol Cell; 1995 Aug; 6(8):1025-35. PubMed ID: 7579705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cAMP antagonizes p21ras-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor.
    Burgering BM; Pronk GJ; van Weeren PC; Chardin P; Bos JL
    EMBO J; 1993 Nov; 12(11):4211-20. PubMed ID: 8223435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of phosphoinositide 3-kinase in activation of ras and mitogen-activated protein kinase by epidermal growth factor.
    Wennström S; Downward J
    Mol Cell Biol; 1999 Jun; 19(6):4279-88. PubMed ID: 10330169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin-induced mitogenesis is Ras dependent but appears to bypass the Raf-dependent cytoplasmic kinase cascade.
    al-Alawi N; Rose DW; Buckmaster C; Ahn N; Rapp U; Meinkoth J; Feramisco JR
    Mol Cell Biol; 1995 Mar; 15(3):1162-8. PubMed ID: 7862110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Ras and mitogen-activated protein kinase pathway by terminal complement complexes is G protein dependent.
    Niculescu F; Rus H; van Biesen T; Shin ML
    J Immunol; 1997 May; 158(9):4405-12. PubMed ID: 9127005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory actions of cyclic adenosine monophosphate and pertussis toxin define two distinct epidermal growth factor-regulated pathways leading to activation of mitogen-activated protein kinase in rat hepatocytes.
    Ginès P; Li X; Brown SE; Nakamura T; Guzelian PS; Heasley LE; Schrier RW; Nemenoff RA
    Hepatology; 1996 May; 23(5):1167-73. PubMed ID: 8621150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK.
    Minden A; Lin A; McMahon M; Lange-Carter C; Dérijard B; Davis RJ; Johnson GL; Karin M
    Science; 1994 Dec; 266(5191):1719-23. PubMed ID: 7992057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzodiazepine peptidomimetic BZA-5B interrupts the MAP kinase activation pathway in H-Ras-transformed Rat-1 cells, but not in untransformed cells.
    James GL; Brown MS; Cobb MH; Goldstein JL
    J Biol Chem; 1994 Nov; 269(44):27705-14. PubMed ID: 7961691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-O-octadecyl-2-O-methyl-glycerophosphocholine inhibits the transduction of growth signals via the MAPK cascade in cultured MCF-7 cells.
    Zhou X; Lu X; Richard C; Xiong W; Litchfield DW; Bittman R; Arthur G
    J Clin Invest; 1996 Aug; 98(4):937-44. PubMed ID: 8770865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 activates p54 mitogen-activated protein (MAP) kinase/stress-activated protein kinase by a pathway that is independent of p21ras, Raf-1, and MAP kinase kinase.
    Bird TA; Kyriakis JM; Tyshler L; Gayle M; Milne A; Virca GD
    J Biol Chem; 1994 Dec; 269(50):31836-44. PubMed ID: 7527398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-Raf-dependent regulation of the MEK-1/mitogen-activated protein kinase pathway in PC12 cells and regulation by cyclic AMP.
    Vaillancourt RR; Gardner AM; Johnson GL
    Mol Cell Biol; 1994 Oct; 14(10):6522-30. PubMed ID: 7935374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cAMP abrogates the p21ras-mitogen-activated protein kinase pathway in fibroblasts.
    Hordijk PL; Verlaan I; Jalink K; van Corven EJ; Moolenaar WH
    J Biol Chem; 1994 Feb; 269(5):3534-8. PubMed ID: 7508916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway.
    Yu SM; Hung LM; Lin CC
    Circulation; 1997 Mar; 95(5):1269-77. PubMed ID: 9054859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling molecules involved in coupling growth hormone receptor to mitogen-activated protein kinase activation.
    Vanderkuur JA; Butch ER; Waters SB; Pessin JE; Guan KL; Carter-Su C
    Endocrinology; 1997 Oct; 138(10):4301-7. PubMed ID: 9322943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways.
    Gu J; Tamura M; Yamada KM
    J Cell Biol; 1998 Nov; 143(5):1375-83. PubMed ID: 9832564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of Raf-1 and B-Raf and Ras-dependent activation of mitogen-activated protein kinase by cyclic AMP in PC12 cells.
    Erhardt P; Troppmair J; Rapp UR; Cooper GM
    Mol Cell Biol; 1995 Oct; 15(10):5524-30. PubMed ID: 7565704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cAMP inhibits the proliferation of retinal pigmented epithelial cells through the inhibition of ERK1/2 in a PKA-independent manner.
    Hecquet C; Lefevre G; Valtink M; Engelmann K; Mascarelli F
    Oncogene; 2002 Sep; 21(39):6101-12. PubMed ID: 12203122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.